Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Biﬁdobacterium biﬁdum & Irritable Bowel Syndrome (IBS)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Clinical data

XXX - Biﬁdobacterium biﬁdum MIMBb75 & Irritable Bowel Syndrome (IBS)

This randomized, double-blind, placebo-controlled trial revealed that Bifidobacterium bifidum MIMBb75 has been shown to effectively alleviate overall symptoms of Irritable Bowel Syndrome (IBS) while also enhancing the quality of life for those affected. Given its high efficacy in treating IBS and its favorable side-effect profile, MIMBb75 emerges as a promising option for IBS therapy (1).

References

(1) Guglielmetti et al. 2011 Alim. Pharmacol. Therapeu. 33: 1123–1132

References (Sources)

Randomised clinical trial: Biﬁdobacterium biﬁdum MIMBb75 signiﬁcantly alleviates irritable bowel syndrome and improves quality of life – a double-blind, placebo-controlled study
Guglielmetti et al. 2011 Alim. Pharmacol. Therapeu. 33: 1123–1132

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!